Skip to main content

Table 3 Dose parameters for investigated HDR brachytherapy plans.

From: MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

 

PTVHDR- PTVDIL

PTVDIL

urethra

 

10Gy HDR brachytherapy

SIB HDR brachytherapy

10Gy HDR brachytherapy

SIB HDR brachytherapy

10Gy HDR brachytherapy

SIB HDR brachytherapy

V90

1.00

1.00

1.00

1.00

0.98

0.99

V100

1.00

1.00

1.00

1.00

0.90

0.90

V125

0.85

0.86

0.94

0.88

0.34

0.35

V150

0.50

0.54

0.71

0.60

0.00

0.00

V200

0.17

0.27

0.24

0.34

0.00

0.00

D100, Gy

9.75

7.50

11.00

15.75

8.75

6.56

D90, Gy

12.00

9.00

13.00

18.38

10.00

7.50

Dmin, Gy

9.37

7.13

10.77

15.08

8.41

6.36

Dmax, Gy

363.09

240.99

83.20

124.70

14.32

10.74

Dav, Gy

17.92

14.90

18.84

29.76

11.57

8.72